Robert Lozuk

Chief Executive Officer at Syantra, Inc.

Health Technology

Commercial Services

Profile

Robert Lozuk is currently the Chief Executive Officer at Syantra, Inc. and also holds a position as Director & Chief Business Officer at Limmi.
Previously, he worked as Senior Vice President-Commercial Operations at Sequenom, Inc.

Robert Lozuk active positions

Companies	Position	Start
Syantra, Inc. Syantra, Inc. Miscellaneous Commercial ServicesCommercial Services Syantra, Inc. engages in the development of cancer detection and treatment technology. It offers Syantra DX - Breast Cancer, a blood-based cancer detection assay that utilizes a novel suite of biomarkers and proprietary artificial intelligence-generated algorithms to provide a positive or negative result. The company was founded by Kristina Rinker and Kenneth Fuh and is headquartered in Calgary, Canada.	Chief Executive Officer	01/11/2023

All active positions of Robert Lozuk

Former positions of Robert Lozuk

Companies	Position	End
SEQUENOM, INC.	Corporate Officer/Principal	-

See the detail of Robert Lozuk's experience

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Robert Lozuk's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	2
Sequenom, Inc. Sequenom, Inc. Medical SpecialtiesHealth Technology Sequenom, Inc. engages in the provision of early patient management information. It develops and commercializes molecular diagnostic testing services that serve women's health and oncology markets. The company was founded by Hubert Koester and Charles R. Cantor in October 09, 1996 and is headquartered in Burlington, NC.	Health Technology
Syantra, Inc. Syantra, Inc. Miscellaneous Commercial ServicesCommercial Services Syantra, Inc. engages in the development of cancer detection and treatment technology. It offers Syantra DX - Breast Cancer, a blood-based cancer detection assay that utilizes a novel suite of biomarkers and proprietary artificial intelligence-generated algorithms to provide a positive or negative result. The company was founded by Kristina Rinker and Kenneth Fuh and is headquartered in Calgary, Canada.	Commercial Services